About SINTOFARM BUCURESTI
ISIN
ROSINTACNOR6
FIGI
BBG000BS8809
Sintofarm SA Bucuresti engages in the manufacture and trade of pharmaceutical products. It offers medicines, suppositories, gels, disinfectants, dietary supplements, active substances, biocides, medical devices, testing kits, and cosmetics. The company was founded in 1973 and is headquartered in Bucharest, Romania.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SINT is 4.80 RON — it has decreased by 13.51% in the past 24 hours. Watch SINTOFARM BUCURESTI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BVB exchange SINTOFARM BUCURESTI stocks are traded under the ticker SINT.
SINT stock has fallen by 13.51% compared to the previous week, the month change is a 13.51% fall, over the last year SINTOFARM BUCURESTI has showed a 2.04% decrease.
No, SINT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SINT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINTOFARM BUCURESTI stock right from TradingView charts — choose your broker and connect to your account.
SINT reached its all-time high on Jul 17, 2007 with the price of 15.50 RON, and its all-time low was 0.82 RON and was reached on Dec 11, 2018. View more price dynamics on SINT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINTOFARM BUCURESTI technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINTOFARM BUCURESTI stock shows the neutral signal. See more of SINTOFARM BUCURESTI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.